Position in LLY
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$3,998,602,577
-$775,101,706 QoQ
Shares Held
4,347,394
-2.1% QoQ
Ownership
0.462%
of shares outstanding
% of Portfolio
2.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 95%
None 5%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $11,353,030,401 across 14 Drug Manufacturers - General names. LLY ranks #1 (35.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,347,394 | $3,998,602,577 | |
| 2 | AZN |
Astrazeneca PLC
|
11,949,424 | $2,356,665,399 | |
| 3 | JNJ |
Johnson & Johnson
|
7,872,478 | $1,924,348,519 | |
| 4 | ABBV |
AbbVie Inc.
|
6,931,036 | $1,507,431,018 | |
| 5 | AMGN |
Amgen Inc
|
1,107,159 | $389,553,892 | |
| 6 | NVS |
Novartis AG
|
2,275,938 | $347,649,529 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,880,199 | $346,459,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,972,639 | $274,926,696 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,998,602,577 | 4,347,394 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,773,704,283 | 4,441,977 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,454,767,862 | 4,527,874 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,418,131,471 | 4,384,862 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,743,529,575 | 4,532,612 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,462,067,196 | 4,484,543 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,574,841,430 | 4,035,083 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,749,401,301 | 4,141,246 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,781,739,121 | 3,575,684 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,942,263,207 | 3,331,955 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,298,045,007 | 2,416,631 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,175,737,548 | 2,507,010 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,147,410,520 | 3,341,129 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,331,902,711 | 3,640,670 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,203,050,187 | 3,720,582 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $1,275,084,728 | 3,932,655 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,454,933,424 | 5,080,607 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,508,265,611 | 5,460,378 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,104,358,233 | 4,779,737 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $1,118,161,764 | 4,871,740 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $936,294,200 | 5,011,745 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,034,131,661 | 6,124,921 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $861,864,952 | 5,822,625 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $913,545,953 | 5,564,295 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $662,809,986 | 4,778,042 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||